SCHEMBL24065796

SCHEMBL24065796

N#Cc1ccc(-c2ccc(-c3ccc(-c4nc(-c5ccc(-c6cccc7ccccc67)cc5)c5ccccc5n4)c4ccccc34)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.43
MEN1 O00255 5/20 0.43
KMT2A Q03164 5/20 0.43
ATM Q13315 2/20 0.43
ABCG2 Q9UNQ0 5/20 0.43
CYP1A2 P05177 4/20 0.43
CYP2C19 P33261 3/20 0.43
CYP2C9 P11712 2/20 0.43
USP1 O94782 1/20 0.40
WDR48 Q8TAF3 1/20 0.40
KDM1A O60341 1/20 0.39
SLC22A12 Q96S37 1/20 0.39
ALDH1A1 P00352 3/20 0.39
CYP3A4 P08684 2/20 0.39
CLK4 Q9HAZ1 2/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 2/20 0.39
HSD17B10 Q99714 2/20 0.39
MAPK1 P28482 1/20 0.39
CYP2D6 P10635 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065725 1.00 ADORA2A (0.43) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065810 0.98 ADORA2A (0.43) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065828 0.95 ABCG2 (0.43) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065794 0.95 MEN1 (0.49) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065726 0.95 MEN1 (0.49) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065795 0.95 ABCG2 (0.43) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065825 0.94 MEN1 (0.50) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065811 0.93 MEN1 (0.49) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065741 0.92 MEN1 (0.50) ADORA2AMEN1KMT2AATMABCG2
SCHEMBL24065766 0.92 MEN1 (0.50) ADORA2AMEN1KMT2AATMABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC4, CRY1, TRPC1 ADORA2A 3738/4885MEN1 780/4885KMT2A 2776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.